Article ID Journal Published Year Pages File Type
8835597 Journal of Surgical Research 2018 7 Pages PDF
Abstract
Etanercept can be a promising agent in mesenteric ischemic reperfusion injury as it does not only inhibit inflammation by blocking tumor necrosis factor-α in circulation but also restores vascular contractility during reflow. These findings support an unexplained recuperative effect of drug beyond its anti-inflammatory effects.
Related Topics
Health Sciences Medicine and Dentistry Surgery
Authors
, , , , ,